Clinical Trial Update: Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Abraxane maintenance after Abraxane plus carboplatin in first-line stage IIIB/IV squamous cell non-small cell lung cancer has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Abraxane plus carboplatin

Snippet

Sponsor: Celgene | Conditions: Squamous Cell Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: COMPLETED | Results posted: 2018-12-07